Description

Divalproex Sodium Delayed-Release & Extended-Release Tablets (250 mg / 500 mg)

Healthy Inc is a specialized global supplier and exporter of advanced neurology, psychiatry, and targeted high-containment mood-stabilizing therapeutics. We provide ultra-high-purity, kinetically stabilized Divalproex Sodium Delayed-Release (DR) and Extended-Release (ER) Tablets (250 mg / 500 mg), manufactured in WHO–GMP certified, strictly humidity-controlled and advanced polymer-coating oral solid dosage facilities. This “Broad-Spectrum Anticonvulsant & Mood Stabilizer” is a massive-volume, highly strategic export to neurology centers, psychiatric hospitals, epilepsy clinics, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, foundational intervention for complex seizures, acute bipolar mania, and migraine prophylaxis.

Product Overview

This highly advanced formulation operates as a profound, centralized electrical and chemical dampener for the brain. It is uniquely engineered as a stable coordination compound (an oligomer) that dissociates into valproate ion in the gastrointestinal tract, delivering massive neuro-stabilizing power with significantly less gastric toxicity than standard valproic acid.

The “GABA-Amplifier & Ion Channel Blocker” Specialist:

• Mechanism 1 (The GABA Surge): Divalproex aggressively elevates the concentration of Gamma-Aminobutyric Acid (GABA), the brain’s primary inhibitory neurotransmitter. It achieves this by inhibiting GABA transaminase (the enzyme that breaks GABA down) and stimulating the enzymes that synthesize it. This massive GABA surge violently dampens neuronal hyper-excitability, stopping the cascading electrical storms that cause both epileptic seizures and bipolar manic episodes.
• Mechanism 2 (Voltage-Gated Sodium Channels): Similar to Phenytoin, Divalproex physically blocks voltage-dependent sodium channels, prolonging their inactivated state. This strictly prevents neurons from firing at the ultra-high frequencies seen during the cortical spread of a seizure or a migraine aura.
• Mechanism 3 (T-Type Calcium Channels): By slightly attenuating T-type calcium channels in the thalamus, Divalproex proves highly effective in stopping “absence seizures” (petit mal), making it a truly broad-spectrum neurological agent.

Product Composition & Strength

We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.

*Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Neurology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Hygroscopic Defense & Enteric Precision (CRITICAL COMPLIANCE): The engineering behind Divalproex defines its clinical tolerability. If the enteric coating fails in the stomach, the patient will suffer agonizing GI distress and vomit the dose, leading to a catastrophic seizure relapse. Our CNS suites utilize strict dehumidification (RH < 30%) to handle the raw API and advanced Wurster fluid-bed processors to apply a flawless, acid-resistant methacrylic polymer shield. This guarantees absolute compliance with originator pharmacokinetics and total patient comfort.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized lifelong management of severe neurological and psychiatric disorders:

• Epilepsy: Monotherapy and adjunctive therapy for complex partial seizures and simple/complex absence seizures.
• Bipolar Disorder: Treatment of acute manic or mixed episodes associated with bipolar disorder, rapidly suppressing racing thoughts, grandiosity, and severe agitation.
• Migraine Prophylaxis: Prophylaxis of migraine headaches (specifically the Extended-Release formulations).

Dosage & Administration

Recommended Dosage (Strictly as per Neurologist/Psychiatrist Guidelines):

• The “Do Not Crush” Mandate (CRITICAL): Tablets MUST be swallowed completely whole. Chewing, crushing, or breaking the tablet instantly destroys the enteric or extended-release coating, causing immediate, severe gastric and systemic toxicity.
• Dosing: Highly individualized based on serum valproate trough levels (target therapeutic range is generally 50 to 125 mcg/mL depending on the indication).

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Hepatotoxicity): Fatal hepatic failure has occurred, usually during the first 6 months of treatment. Children under the age of 2 years are at a considerably increased risk of fatal hepatotoxicity. Liver function tests (LFTs) must be performed prior to therapy and at frequent intervals thereafter.
• BLACK BOX WARNING (Fetal Risk / Teratogenicity): Divalproex is highly teratogenic. It causes severe neural tube defects (e.g., spina bifida) and drastically decreased IQ scores following in utero exposure. It is strictly contraindicated for migraine prophylaxis in pregnant women and should only be used in epilepsy/bipolar disorder if alternative medications have failed.
• BLACK BOX WARNING (Pancreatitis): Cases of life-threatening hemorrhagic pancreatitis have been reported in both children and adults. Patients experiencing severe abdominal pain, nausea, and vomiting must be evaluated immediately.
• Hyperammonemia: Can cause severely elevated blood ammonia levels, leading to lethal hyperammonemic encephalopathy (confusion, lethargy, coma).

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Neurology/Psychiatry Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Anticonvulsants, Mood Stabilizers, and Complex Enteric-Coated Formulations. Whether you are looking for a reliable Government Tender Supplier for epilepsy programs in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.